Why the ‘Brazilian Ozempic’ May Take Time and the Semaglutide Patent Expiration Shouldn’t Lower Prices

!!!

Issue Mar 18-24 2026: The patent for semaglutide, the active ingredient in Ozempic, expired on March 20, 2026, in Brazil. But the expectation of buying the slimming pen at a lower price is not expected to materialize this month, due to regulatory and industrial difficulties.

To read the full content subscribe today!